1/10
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
hemophilia C
factor XI deficiency
What is a benefit to inhibiting factor XI?
could protect against thrombosis without significantly increasing risk of spontaneous bleed
categories of factor XI inhibitors
- monoclonal antibodies
- synthetic small molecules
- antisense oligonucleotides
MOA of monoclonal antibodies
directly binds to Factor XI/XIa to inhibit Factor XI activation or activity
monoclonal antibodie agents
- abelacimab
- osocimab
- xisomab 3G3
MOA of synthetic small molecules
binds to Factor XIa
synthetic small molecules agents
- asundexian
- milvexian
MOA of asundexian
binds reversibly to the active unit of Factor XIa
MOA of milvexian
binds to the active unit of Factor XIa
MOA of antisense oligonucleotides
binds sequence specifically to target mRNA
-> mRNA can no longer be read
-> translation of target protein cannot occur
antisense oligonucleotide agents
- IONIS-FXI-LRx
- fesomersen